Bio-Path Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-8.67	-9.89	-16.08	-13.87	-10.44	Upgrade
Depreciation & Amortization	0.1	0.16	0.18	0.18	0.16	Upgrade
Other Amortization	0.08	-	-	-	-	Upgrade
Stock-Based Compensation	0.2	0.57	0.73	0.85	0.82	Upgrade
Other Operating Activities	0.22	-2.08	0.27	-	-	Upgrade
Change in Accounts Payable	4.62	1.41	0.23	0.7	-0.2	Upgrade
Change in Other Net Operating Assets	1.86	-0.73	3.13	-2.96	-0.26	Upgrade
Operating Cash Flow	-1.6	-10.58	-11.54	-15.1	-9.92	Upgrade
Capital Expenditures	-	-	-	-0.02	-0.07	Upgrade
Investing Cash Flow	-	-	-	-0.02	-0.07	Upgrade
Long-Term Debt Issued	0.42	-	-	-	-	Upgrade
Net Debt Issued (Repaid)	0.42	-	-	-	-	Upgrade
Issuance of Common Stock	0	10.7	2.2	1.73	20.01	Upgrade
Financing Cash Flow	0.42	10.7	2.2	1.73	20.01	Upgrade
Net Cash Flow	-1.17	0.12	-9.33	-13.39	10.02	Upgrade
Free Cash Flow	-1.6	-10.58	-11.54	-15.12	-9.99	Upgrade
Free Cash Flow Per Share	-0.20	-4.40	-24.13	-41.55	-29.70	Upgrade
Levered Free Cash Flow	2.18	-5.97	-5.52	-9.85	-5.98	Upgrade
Unlevered Free Cash Flow	2.23	-5.97	-5.52	-9.85	-5.98	Upgrade
Change in Working Capital	6.49	0.68	3.36	-2.26	-0.46	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.